Skip to main content

Table 2 Lipid profile of dyslipidemic patients and controls at baseline and after 1 year

From: Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients

 

Dyslipidemic patients (n = 15)

Controls (n = 15)

 

Baseline

After 1 year

Baseline

After 1 year

Total cholesterol (mg/dl)

276 (256–330)

204 (171–232)*

245 (188–266)°

188 (165–200)

HDL-cholesterol (mg/dl)

50 (47–57)

52 (49–65)

56 (47–63)

53 (46–65)

LDL-cholesterol (mg/dl)

202 (191–246)

118 (103–149)*

163 (116–175)°

112 (87–122)

Triglycerides (mg/dl)

141 (115–190)

144 (87–154)

159 (74–198)

133 (84–160)

Apoliprotein B (mg/dl)

164 (157–219)

100 (86–119)*

140 (119–157)°

149 (128–185)

Apoliprotein A (mg/dl)

143 (135–162)

141 (136–175)

105 (91–146)

99 (77–116)

  1. *vs baseline (p < 0.0001).
  2. °vs dyslipidemic patients at baseline (p < 0.001).